BENEVENTI, FAUSTA
 Distribuzione geografica
Continente #
NA - Nord America 2.984
AS - Asia 1.736
EU - Europa 1.334
SA - Sud America 259
Continente sconosciuto - Info sul continente non disponibili 91
AF - Africa 77
OC - Oceania 5
Totale 6.486
Nazione #
US - Stati Uniti d'America 2.883
CN - Cina 755
SG - Singapore 397
IE - Irlanda 307
VN - Vietnam 211
RU - Federazione Russa 209
BR - Brasile 194
DE - Germania 173
FI - Finlandia 150
HK - Hong Kong 137
IT - Italia 133
FR - Francia 78
GB - Regno Unito 75
UA - Ucraina 71
IN - India 60
ZA - Sudafrica 48
SE - Svezia 43
CA - Canada 40
BD - Bangladesh 26
AR - Argentina 23
JP - Giappone 23
PL - Polonia 21
TR - Turchia 18
IQ - Iraq 16
MX - Messico 16
ID - Indonesia 14
BE - Belgio 13
EC - Ecuador 12
ES - Italia 12
SA - Arabia Saudita 12
NL - Olanda 11
IR - Iran 10
IL - Israele 9
VE - Venezuela 9
CO - Colombia 7
CR - Costa Rica 7
MA - Marocco 7
PK - Pakistan 7
GT - Guatemala 6
NI - Nicaragua 6
TT - Trinidad e Tobago 6
AT - Austria 5
AZ - Azerbaigian 5
CL - Cile 5
KE - Kenya 5
LT - Lituania 5
RS - Serbia 5
AU - Australia 4
EG - Egitto 4
JM - Giamaica 4
KG - Kirghizistan 4
LB - Libano 4
MY - Malesia 4
PT - Portogallo 4
SV - El Salvador 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
DZ - Algeria 3
GP - Guadalupe 3
HN - Honduras 3
PY - Paraguay 3
SC - Seychelles 3
TH - Thailandia 3
UZ - Uzbekistan 3
BG - Bulgaria 2
CW - ???statistics.table.value.countryCode.CW??? 2
CZ - Repubblica Ceca 2
GR - Grecia 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RO - Romania 2
TN - Tunisia 2
UY - Uruguay 2
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
KI - Kiribati 1
KR - Corea 1
KW - Kuwait 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
PH - Filippine 1
QA - Qatar 1
Totale 6.393
Città #
Dublin 305
San Jose 280
Chandler 271
Ashburn 254
Singapore 215
Dallas 186
Beijing 157
Hong Kong 136
Nanjing 132
Jacksonville 112
Council Bluffs 109
Boardman 93
Los Angeles 86
Ho Chi Minh City 74
Munich 74
Helsinki 61
Ann Arbor 53
New York 50
Princeton 50
Lauterbourg 49
Johannesburg 48
Lawrence 48
Wilmington 47
Nanchang 45
Hanoi 43
Medford 40
Jiaxing 38
Moscow 37
Shanghai 37
Hangzhou 36
Hebei 36
Turku 34
Changsha 32
Shenyang 30
Santa Clara 29
Milan 25
Redondo Beach 25
São Paulo 22
Tianjin 22
Tokyo 22
Denver 20
Buffalo 19
Pavia 19
Woodbridge 18
Orem 17
Chicago 16
Warsaw 16
Brooklyn 15
Atlanta 14
Montreal 14
Toronto 14
Brussels 13
Boston 12
Haiphong 12
London 12
Da Nang 11
Ankara 10
Dong Ket 10
Falkenstein 10
Manchester 10
Chennai 9
Frankfurt am Main 9
Houston 9
Mumbai 9
San Francisco 9
Norwalk 8
Rio de Janeiro 8
Rome 8
Stockholm 8
San José 7
Washington 7
Amsterdam 6
Jinan 6
Mexico City 6
Naples 6
Pune 6
Queens 6
Quito 6
Baghdad 5
Belo Horizonte 5
Falls Church 5
Greenville 5
Guangzhou 5
Guatemala City 5
Guayaquil 5
Jeddah 5
Managua 5
Nairobi 5
North Bergen 5
Nuremberg 5
Paris 5
Baku 4
Bishkek 4
Buenos Aires 4
Caracas 4
Charlotte 4
Newark 4
Phoenix 4
Poplar 4
Riyadh 4
Totale 3.959
Nome #
Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women. 432
Adolescent and adult uterine volume and uterine artery Doppler blood flow among subjects treated with bone marrow transplantation or chemotherapy in pediatric age: a case-control study. 204
Gonadal and uterine function in female survivors treated by chemotherapy, radiotherapy, and/or bone marrow transplantation for childhood malignant and non-malignant diseases. 187
First trimester pregnancy-associated plasma protein-A in pregnancies complicated by subsequent gestational diabetes 178
Role of Breast Ultrasonography in the Diagnosis of Precocious Puberty 153
Prevalence of undiagnosed autoimmune rheumatic diseases in the first trimester of pregnancy. Results of a two steps strategy using a self administered questionnaire and autoantibody testing. 148
Circulating endothelial progenitor cells during pregnancy in multiple sclerosis 140
Infertility and recurrent miscarriage in a patient with autoimmune atrophic gastritis 129
Soluble HLA-G in pregnancies complicated by autoimmune rheumatic diseases 128
LOWPREGNANCY NITRIC OXYDE (NO) CIRCULATING LEVELS ARE ASSOCIATED WITH HYPERTENSION PERSISTENCE AFTER THE DELIVERY 125
Vaginal development and sexual functioning in young women after stem cell transplantation, chemotherapy, and/or radiotherapy for childhood hematological diseases 125
Uterine artery Doppler velocimetry and obstetric outcomes in connective tissue diseases diagnosed during the first trimester of pregnancy. 125
Endothelial Progenitor Cell CD34+ and CD133+ Concentrations and Soluble HLA-G Concentrations During Pregnancy and in Cord Blood in Undifferentiated Connective Tissue Diseases Compared to Controls 125
contraccezione della donna diabetica 124
Temporal variation in soluble human leukocyte antigen-G (sHLA-G) and pregnancy-associated plasma protein A (PAPP-A) in pregnancies complicated by gestational diabetes mellitus and in controls. 123
A first-trimester serum TSH in the 4-10 mIU/L range is associated with obstetric complications in thyroid peroxidase antibody-negative women 121
The impact of first-trimester serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A on the diagnosis of fetal growth restriction and small for gestational age infant 121
Involvement of endogenous gabaergic system in the modulation of gonadotropin secretion in normal cycling women. 117
CONTRIBUTION OF FETAL HLA-C LIGANDS AND MATERNAL KIR RECEPTORS IN THE EVOLUTION OF GESTATIONAL HYPERTENSION TO OVERT PREECLAMPSIA 116
The effect of newly diagnosed undifferentiated connective tissue disease on pregnancy outcome 116
The impact of various entities of antiphospholipid antibodies positivity on adverse pregnancy outcome. An epidemiological perspective 116
Prevalence and significance of previously undiagnosed rheumatic diseases in pregnancy 114
Connective tissue diseases and autoimmune thyroid disorders in the first trimester of pregnancy 114
The Immunosignature of Mother/Fetus Couples in Gestational Diabetes Mellitus: Role of HLA-G 14 bp ins/del and PAPP-A A/C Polymorphisms in the Uterine Inflammatory Milieu 113
Gestational diabetes mellitus: Including serum pregnancy-associated plasma protein-A testing in the clinical management of primiparous women? A case–control study 112
Combined use of goserelin acetate and human menopausal gonadotropin in the induction of follicular growth in a program of fertilization in vitro and embryo transfer 112
Association between previously unknown connective tissue disease and subclinical hypothyroidism diagnosed during first trimester of pregnancy 112
Early, incomplete, or preclinical autoimmune systemic rheumatic diseases and pregnancy outcome 110
Maternal and fetal Leptin and interleukin 33 concentrations in pregnancy complicated by obesity and preeclampsia 110
Undifferentiated connective tissue diseases and adverse pregnancy outcomes. An undervalued association? 109
Use of insulin degludec in pregnancy: two case reports and a literature review 109
Role of placental inflammatory mediators and growth factors in patients with rheumatic diseases with a focus on systemic sclerosis 109
Impact of pregnancy on progression of preclinical autoimmune disorders: a prospective cohort study 108
The impact of unrecognized autoimmune rheumatic diseases on the incidence of preeclampsia and fetal growth restriction: A longitudinal cohort study 108
Effects of the GABAergic drug, sodium valproate, on the prolactin release evoked by pharmacological stimuli in normal women. 105
Efficacy of a screening strategy for the detection of rheumatic diseases in early pregnancy during COVID-19 pandemic 104
Effects of uncomplicated vaginal delivery and epidural analgesia on fetal arterial acid-base parameters at birth in gestational diabetes. 103
SOLUBLE HLA-G IN THE CORD: THE FETUS' RESPONSE TO MATERNAL INFLAMMATION 103
Infertilità : aspetti clinici e diagnostica per immagini 102
Utility of breast ultrasonography in the diagnostic work-up of precocious puberty and proposal of a prognostic index for identifying girls with rapidly progressive central precocious puberty. 99
Thyroid autoimmunity and adverse pregnancy outcomes: a prospective cohort study 96
Maternal and foetal placental vascular malperfusion in pregnancies with anti-phospholipid antibodies 94
Pre-partum Proteinuria Is A Risk Factor For Short-termi High Blood Pressure Persistence After Delivery 93
Mild-to-moderate foeto-maternal haemorrhage in the third trimester and at term of pregnancy: Quantitative determination and clinical-diagnostic evaluation 92
Isolated thrombocytopenia in pregnancy: A monocentric retrospective study of 63 pregnancies in 59 women 91
Le precocità sessuali 88
Soluble HLA-G concentrations in maternal blood and cervical vaginal fluid of pregnant women with preterm premature rupture of membranes 87
Ultrasonography endometrial patterns in different hormonal treatments to induce ovulation. 84
Placental pathologic features in thyroid autoimmunity 83
Prevention of puerperal lactation by a single oral administration of the new prolactin-inhibiting drug, cabergoline. 81
Malformazioni dell'apparato genitale femminile 81
Placental pathologic features in obesity 80
Soluble HLA-G concentrations in obese women during pregnancy and in cord blood 78
Relationship between maternal obesity and first-trimester TSH in women with negative anti-TPO antibodies 63
Monitoring the Blood Levels of Hla-g and Pregnancy Associated Plasma Protein-a (papp-a) In Normal Pregnancies 60
null 26
Totale 6.486
Categoria #
all - tutte 26.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.206


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022197 0 0 0 0 4 4 2 12 12 3 34 126
2022/2023783 69 68 12 31 80 69 2 50 356 8 24 14
2023/2024338 58 64 14 15 22 63 8 21 4 14 10 45
2024/2025957 23 59 29 31 9 57 46 64 257 35 147 200
2025/20262.274 183 180 248 300 268 117 398 116 213 150 51 50
2026/2027933 306 114 148 221 144 0 0 0 0 0 0 0
Totale 6.486